Triboluminescence from Pharmaceutical Formulations.
Casey J SmithScott R GriffinGregory S EakinsFengyuan DengJulia K WhiteSatyanarayana ThirunahariSrividya RamakrishnanAtanu SanguptaSiwei ZhangJulie NovakZhen LiuTimothy RhodesGarth J SimpsonPublished in: Analytical chemistry (2018)
Triboluminescence (TL) is shown to enable selective detection of trace crystallinity within nominally amorphous solid dispersions (ASDs). ASDs are increasingly used for the preparation of pharmaceutical formulations, the physical stability of which can be negatively impacted by trace crystallinity introduced during manufacturing or storage. In the present study, TL measurements of a model ASD consisting of griseofulvin in polyethylene glycol produced limits of detection of 140 ppm. Separate studies of the particle size dependence of sucrose crystals and the dependence on polymorphism in clopidogrel bisulfate particles are both consistent with a mechanism for TL closely linked to the piezoelectric response of the crystalline fraction. Whereas disordered polymeric materials cannot support piezoelectric activity, molecular crystals produced from homochiral molecules adopt crystal structures that are overwhelmingly symmetry-allowed for piezoelectricity. Consequently, TL may provide a broadly applicable and simple experimental route for sensitive detection of trace crystallinity within nominally amorphous materials.
Keyphrases
- room temperature
- sensitive detection
- loop mediated isothermal amplification
- heavy metals
- quantum dots
- label free
- real time pcr
- acute coronary syndrome
- autism spectrum disorder
- ionic liquid
- physical activity
- drug delivery
- percutaneous coronary intervention
- coronary artery disease
- intellectual disability
- cancer therapy
- antiplatelet therapy
- drug release
- high resolution
- atrial fibrillation
- molecularly imprinted